These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20022377

  • 21. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP, Bryson S, Nieva JL, Pai EF.
    J Mol Biol; 2008 Dec 12; 384(2):377-92. PubMed ID: 18824005
    [Abstract] [Full Text] [Related]

  • 22. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA, Morfeldt-Månsson L, Rosen J, Jondal M, Wahren B.
    Clin Exp Immunol; 1989 May 01; 76(2):216-21. PubMed ID: 2503275
    [Abstract] [Full Text] [Related]

  • 26. Baculovirus display of single chain antibody (scFv) using a novel signal peptide.
    Kitidee K, Nangola S, Gonzalez G, Boulanger P, Tayapiwatana C, Hong SS.
    BMC Biotechnol; 2010 Nov 19; 10():80. PubMed ID: 21092083
    [Abstract] [Full Text] [Related]

  • 27. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W, Mazzuca P, Yuan W, Varney K, Bugatti A, Cagnotto A, Giagulli C, Rusnati M, Marsico S, Diomede L, Salmona M, Caruso A, Lu W, Caccuri F.
    Biochim Biophys Acta Gen Subj; 2019 Jan 19; 1863(1):13-24. PubMed ID: 30248376
    [Abstract] [Full Text] [Related]

  • 28. Antibody neutralization and escape by HIV-1.
    Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.
    Nature; 2003 Mar 20; 422(6929):307-12. PubMed ID: 12646921
    [Abstract] [Full Text] [Related]

  • 29. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
    Sanchez-Merino V, Farrow MA, Brewster F, Somasundaran M, Luzuriaga K.
    J Infect Dis; 2008 Jan 15; 197(2):300-8. PubMed ID: 18177249
    [Abstract] [Full Text] [Related]

  • 30. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.
    Koti M, Farrugia W, Nagy E, Ramsland PA, Kaushik AK.
    Mol Immunol; 2010 Feb 15; 47(5):953-60. PubMed ID: 20006385
    [Abstract] [Full Text] [Related]

  • 31. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 15; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 32. Molecular dynamics analysis of HIV-1 matrix protein: clarifying differences between crystallographic and solution structures.
    Verli H, Calazans A, Brindeiro R, Tanuri A, Guimarães JA.
    J Mol Graph Model; 2007 Jul 15; 26(1):62-8. PubMed ID: 17067836
    [Abstract] [Full Text] [Related]

  • 33. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
    Sánchez-Martínez S, Lorizate M, Hermann K, Kunert R, Basañez G, Nieva JL.
    FEBS Lett; 2006 Apr 17; 580(9):2395-99. PubMed ID: 16616522
    [Abstract] [Full Text] [Related]

  • 34. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.
    J Pept Sci; 1995 Apr 17; 1(2):109-23. PubMed ID: 9222988
    [Abstract] [Full Text] [Related]

  • 35. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y.
    Microbiol Immunol; 1995 Apr 17; 39(10):775-85. PubMed ID: 8577268
    [Abstract] [Full Text] [Related]

  • 36. A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor.
    Saitoh A, Tanaka N, Nakata A, Ikuta K, Shinagawa H.
    Microbiol Immunol; 1992 Apr 17; 36(1):105-11. PubMed ID: 1584067
    [Abstract] [Full Text] [Related]

  • 37. Antibody detection by using a FRET-based protein conformational switch.
    Golynskiy MV, Rurup WF, Merkx M.
    Chembiochem; 2010 Nov 02; 11(16):2264-7. PubMed ID: 20928879
    [No Abstract] [Full Text] [Related]

  • 38. A single point mutation in framework region 3 of heavy chain affects viral neutralization dynamics of single-chain Fv against bovine herpes virus type 1.
    Koti M, Nagy E, Kaushik AK.
    Vaccine; 2011 Oct 19; 29(45):7905-12. PubMed ID: 21872632
    [Abstract] [Full Text] [Related]

  • 39. Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.
    Cogniaux J, De Schepper N, Blondiau ML, Cornet B, Horal P, Vahlne A.
    J Immunol Methods; 1990 Apr 17; 128(2):165-75. PubMed ID: 1691236
    [Abstract] [Full Text] [Related]

  • 40. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens.
    Robert-Hebmann V, Emiliani S, Jean F, Resnicoff M, Traincard F, Devaux C.
    Mol Immunol; 1992 Jun 17; 29(6):729-38. PubMed ID: 1376412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.